[1]
Haj Manochehri, M., Azizi, F., Rahimi, M. and Omrani, M.D. 2018. Association of rs16917496 polymorphism at the miR-502 binding site in the SET8 3’UTR with the risk of Prostate Cancer and benign prostatic hyperplasia. Novelty in Biomedicine. 6, 2 (Apr. 2018), 74–78. DOI:https://doi.org/10.22037/nbm.v6i2.18292.